Abstract
The effects of mildronate [3(2,2,2-trimethylhydrazinium) propionate dihydrate], γ-butyrobetaine (GBB) and their combination (neomildronate) on the level of thyroid hormones and some intermediates of basal metabolism (free fatty acids, triglycerides, glucose) in serum of laboratory rats with various dysfunctions of thyroid glands including idiopathic hyperfunction and also hypofunction induced by administration of 6-propyl-2-thiouracil (PTU) or L-carnitine administration. Intraperitoneal injections of mildronate (150 mg/kg) during 20 days to male Wistar rats with elevated level of thyroid hormones and basal metabolism normalized thyroxin level and parameters of lipid metabolism in serum. Administration of the compounds studied to rats with hypothyroidism induced by administration of PTU or L-carnitine did not influence natural recovery of the hormonal level. Possible biochemical role of these pharmacological treatments is discussed in terms of in regulation of thyroid gland function.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Logunova, L.V., Sutulov, Yu.L., Bagatova, F.E., Epakhiev, A.A., and Kudziev, I.G., Tez. Dokl. na 4 mezhdunar. kongr. “Immunoreabilitatsiya i reabilitatsiya v med.” Sochi, 1998 (4 Int. Congr. “Immunorehabilitation and Rehabilitation in Medicine”), J. Immunorehabil., 1998, vol. 8, p. 150.
Shutenko, Zh.V., Meirena, D.V., Kagan, T.I., S’yakste, N.I., and Kalvin’sh, I.Y., Khim.-Farm. Zh., 1995, vol. 29, pp. 13–17.
Sjakste, N., Gutcaits, A., and Kalvinsh, I., CSN Drug Reviews, 2005, vol. 11(2), pp. 151–168.
Benvenga, S., Ruggeri, R.M., Russo, A., Lapa, D., Campenni, A., and Trimarchi, F., Clin. Endocrinol. Metab., 2001, vol. 86(8), pp. 3579–3594.
Galland, S., Georges, B., Le Borg, F., Conductier, G., Dias, J.V., and Demarquoy, J., Cell. Mol. Life Sci., 2002, vol. 59, pp. 540–545.
Quesada, A., Sainz, J., Wangensteen, R., Roddriquez-Gomez, I., Vargas, F., and Osuna, A., Eur. J. Endocrinol., 2002, vol. 147, pp. 117–122.
Murakhmedov, M.A. and Turakulov, Ya.Kh., Vestn. AMN SSSR, 1983, vol. 2, pp. 64–69.
Ahren, B., Acta Physiol. Scandinavica, 2001, vol. 171(2), pp. 161–167.
Nikkila, E.A. and Kekki, M., J. Clin. Invest., 1972, vol. 51, pp. 2103–2114.
Mokuno, T., Uchimura, K., Hayashi, R., Nayakawa, N., Makino, M., Nagata, M., Kalizawa, K., Sawai, G., Kotake, M., Oda, N., Nakai, A., Nagosaka, A., and Itoh, M., J. Endocrinol., 1990, vol. 160, pp. 285–289.
Kravchenya, N.A., Gorenshtein, B.I., Dezhurova, G.A., Lukashik, N.K., and Ostrovskii, Yu.M., Probl. endokrinol., 1989, vol. 35, pp. 64–68.
Ito, F. and Frankel, G., J. Gen. Physiol., 1957, vol. 41(2), pp. 279–288.
Author information
Authors and Affiliations
Additional information
Original Russian Text © E.M. Sharipova, E.V. Salna, M.Ya. Dzintare, L.Ya. Lauberte, D.V. Meirena, N.I. Sjakste, V.S. Gordjushina, I. Kalvinsh, 2008, published in Biomeditsinskaya Khimiya.
Rights and permissions
About this article
Cite this article
Sharipova, E.M., Salna, E.V., Dzintare, M.Y. et al. The effect of mildronate and related substances on levels of thyroid hormones and some intermediates of lipid and carbohydrate metabolism in hyperthyroid and hypothyroid rats. Biochem. Moscow Suppl. Ser. B 2, 169–175 (2008). https://doi.org/10.1134/S1990750808020078
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990750808020078